News

Eliquis, Pfizer and Bristol Myers

Major drugmakers offer big discount on blood thinner Eliquis
Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient models from Eli Lilly and Novo Nordisk.
Bristol Myers, Pfizer to sell blood thinner Eliquis directly to US patients
Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to cash-paying U.S. patients at a discount to its listed price as drugmakers are under pressure from the Trump administration to lower prices.
Pfizer (PFE) and Bristol Myers (BMY) Launch Direct-to-Patient Eliquis Program
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer, Inc. (NYSE:PFE) have announced a direct-to-patient program for Eliquis (apixaban),
Bristol-Myers, Pfizer slash Eliquis price for cash-paying patients
Drugmakers will offer Eliquis at a 43% discount to uninsured U.S. patients, bypassing insurers and PBMs New $346 monthly price remains far higher than
BMS, Pfizer take DTC route for blood thinner Eliquis
The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for the drug out-of-pocket with a 40% or greater discount to its current list price, providing a new option for uninsured, underinsured, or self-pay patients.
Bristol Myers Squibb, Pfizer announce discounted direct-to-patient Eliquis
The reduced rate will still be almost 10 times the average monthly out-of-pocket costs paid by commercially insured patients.
Bristol Myers, Pfizer offer Eliquis at a discount through DTC online program
Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs directly to patients, Bristol Myers Squibb and Pfizer are doing the same with their megablockbuster blood thinner Eliquis.
Bristol‑Myers Squibb, Pfizer Set To Launch Direct‑To‑Patient Eliquis At 40% Off
Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and nationwide delivery.
Bristol-Myers and Pfizer to Offer Blockbuster Blood Thinner at Discount
The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.
Pfizer, BMS offer direct-to-patient Eliquis at 40% discount
Pfizer and Bristol Myers Squibb have launched a direct-to-patient program offering their blood thinner Eliquis at a 40% discount for cash-paying patients.  The list price for Eliquis (apixaban) is $606 for a 30-day supply,
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
The companies' new effort would bypass traditional middlemen to cut the drug's monthly cost from a list price of around $606 to $346.
The American Journal of Managed Care3d
Direct-to-Patient Apixaban Program Aims to Expand Access, Lower Out-of-Pocket Costs
Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.
Dear Doctor: Man’s worry over AFib meds is reasonable. But doing nothing is even more concerning
Many studies have shown that even though these medicines have risks, these risks are much lower than the risk of a stroke ...
Devdiscourse2d
Pivoting Paths: Key Developments in Health Sector
The health landscape sees pivots as companies adjust strategies: Bristol Myers and Pfizer offer discounts on Eliquis, Newcastle University's IVF technique prevents genetic diseases, and Juul's ...
Your Good Health: Powerful drugs recommended for AFib make patient reluctant
The reason you should reconsider is that the alternative (doing nothing) is worse. Your risk of having a blood clot, ...